Amgen v. Sandoz – D.N.J.

2017 LMG LIFE SCIENCES AWARDS GOODWIN IP PRACTICE IN THREE CATEGORIES

Updated Guide to the Biosimilars Patent Dance

In-house attorneys and executives can request a gratis copy of Goodwin's updated Guide to the Biosimilars Patent Dance

BioSimilars Regulatory IP Guide

We’re on Twitter!

Follow us @Big_Molecule for updates

Subscribe

Big Molecule Watch Monthly Digest
Monthly Digest provides analyses on regulatory issues, litigation, legislation, and other news in the ever-developing world of biosimilars. Subscribe>>

Get Real Time Blog Posts
You will receive a verification email once you submit this form to activate your real time Feedburner email subscription to Goodwin Procter - Big Molecule Watch Blog. Subscribe>>

Resources

FDA

Biosimilars Guidances

Biologics Guidances

FDA Biosimilars Page

Purple Book/Approved Biosimilars

FDA-Approved aBLAs

CANADA

Guidances and legislation

EMA

Guidelines

Approved Products